InvestorsHub Logo

Rollgard1

10/17/21 4:51 AM

#3392 RE: JJAAMMAANN #3391

Excellent Post...as I was thinking along those same lines weeks ago...

reviewing some notes.Nice.Here is a note from the clinical site for patients as they will be followed for 60 days from dosing...


What Does the Study Involve?
Participation in the study will last for up to 60 days.
The study is divided into 3 main parts:
1. You will visit a local doctor’s office. Tests will be done and your medical history
will be reviewed to find out if you can be in the study.
2. If you qualify for the study, you will begin receiving study treatment with
either Tempol or placebo. Placebo is an inactive substance that helps us better
understand the effects of the investigational drug. You will attend about 6
study visits over the next month to collect blood and urine samples and to
check on your health. These visits may take place in the research clinic, your
home, or online. You will take the study treatment twice each day for the first
2 weeks during this period.
3. About 6 weeks later you will have 1 final follow-up visit to check on your health.


https://earlycovidstudy.com/wp-content/uploads/2021/08/APC400-03_Study_Overview.pdf



All is Good.Wait until it gets better.Patience...Thanks Roll

cougar24

10/17/21 8:22 AM

#3393 RE: JJAAMMAANN #3391

Thanks JJ. Hope they get the quarterly reports filed before zimhi decision and and interim Tempol results. Institutions can’t buy into a company delinquent with quarterly reports, and we know that they are the real movers of stocks, not retail traders like the Reddit crowd believes.